Gilead Sciences, Inc. (GILD) financial statements (2020 and earlier)

Company profile

Business Address 333 LAKESIDE DR
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24,35230,08925,51011,89514,60710,1282,132
Cash and cash equivalents11,63117,9407,5888,22912,85110,0272,113
Short-term investments12,72112,14917,9223,6661,75610119
Receivables3,5823,3273,8514,5145,8544,6352,100
Inventory, net of allowances, customer advances and progress billings9228148011,5871,9551,3862,056
Inventory9228148011,5871,9551,3862,056
Prepaid expense   231240194166
Other current assets   1,06250647292
Other undisclosed current assets1,4401,6061,6611,1561,601899729
Total current assets:30,29635,83631,82320,44524,76317,7147,274
Noncurrent Assets
Inventory, Noncurrent     489 
Property, plant and equipment4,5024,0063,2952,8652,2761,6741,166
Long-term investments and receivables1,4881,42311,18420,48511,6011,598439
Long-term investments1,4881,42311,18420,48511,6011,598439
Intangible assets, net (including goodwill)17,90319,85521,25910,14311,41912,24513,069
Goodwill4,1174,1174,1591,1721,1721,1721,169
Intangible assets, net (excluding goodwill)13,78615,73817,1008,97110,24711,07311,900
Prepaid expense   423400466199
Other noncurrent assets7,4382,5552,7222,2141,056731195
Other undisclosed noncurrent assets   402324(253)155
Total noncurrent assets:31,33127,83938,46036,53227,07616,95015,223
TOTAL ASSETS:61,62763,67570,28356,97751,83934,66422,497
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,7873,9294,1843,9964,7952,8281,510
Accounts payable7137908141,2061,1789551,256
Accrued liabilities3,0743,1393,3702,7903,1721,452 
Employee-related liabilities    380316244
Taxes payable    6510511
Debt2,4992,7482,747 9834832,697
Deferred revenue and credits 202440134111
Other undisclosed current liabilities3,4733,9284,7045,0213,6732,3162,007
Total current liabilities:9,75910,60511,6359,2199,8915,7616,325
Noncurrent Liabilities
Long-term debt and lease obligation22,09424,57430,79526,34621,19511,9213,939
Long-term debt, excluding current maturities22,09424,57430,79526,34621,19511,9213,939
Liabilities, other than long-term debt7,1246,9627,3522,0491,6381,148424
Deferred revenue and credits    22
Accounts payable and accrued liabilities6,1155,9226,7941,7531,243562 
Accrued income taxes162
Deferred tax liabilities, net    5183
Other liabilities1,0091,040558296395535157
Total noncurrent liabilities:29,21831,53638,14728,39522,83313,0694,363
Total liabilities:38,97742,14149,78237,61432,72418,83010,688
Temporary equity, carrying amount    21564
Stockholders' equity
Stockholders' equity attributable to parent22,52521,38720,44218,88718,53415,42611,369
Common stock1111122
Additional paid in capital3,0512,2821,2644544442,3915,387
Accumulated other comprehensive income (loss)858016527888301(124)
Retained earnings19,38819,02419,01218,15418,00112,7326,105
Stockholders' equity attributable to noncontrolling interest12514759476579393375
Total stockholders' equity:22,65021,53420,50119,36319,11315,81911,745
TOTAL LIABILITIES AND EQUITY:61,62763,67570,28356,97751,83934,66422,497

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues22,44922,12726,10730,39032,63924,89011,202
Revenue, net26,10730,39032,63924,89011,202
Cost of revenue
(Cost of Goods and Services Sold)
(4,675)(4,853)(4,371)(4,261)(4,006)(3,788)(2,859)
Gross profit:17,77417,27421,73626,12928,63321,1028,343
Operating expenses(14,287)(9,894)(7,612)(8,928)(6,440)(5,837)(3,819)
Other undisclosed operating income800820 432   
Operating income:4,2878,20014,12417,63322,19315,2654,524
Nonoperating income (expense)1,8686765234281543(9)
Investment income, nonoperating22(2)  117136(17)
Foreign currency transaction loss, before tax     (4)(4)
Interest and debt expense(995)(1,077)(1,118)(964)(688)(412)(307)
Income from continuing operations before income taxes:5,1607,79913,52917,09721,65914,8564,208
Income tax expense (benefit)204(2,339)(8,885)(3,609)(3,553)(2,797)(1,151)
Net income:5,3645,4604,64413,48818,10612,0593,057
Net income (loss) attributable to noncontrolling interest22(5)(16)1324218
Net income available to common stockholders, diluted:5,3865,4554,62813,50118,10812,1013,075

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:5,3645,4604,64413,48818,10612,0593,057
Other comprehensive income (loss)5208(113)190(213)425(79)
Comprehensive income:5,3695,6684,53113,67817,89312,4842,978
Comprehensive income (loss), net of tax, attributable to noncontrolling interest22(5)(16)13242(18)
Other undisclosed comprehensive income, net of tax, attributable to parent      35
Comprehensive income, net of tax, attributable to parent:5,3915,6634,51513,69117,89512,5262,996

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: